These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38215546)

  • 1. The antioxidant and anti-inflammatory activities of avasopasem manganese in age-associated, cisplatin-induced renal injury.
    Mapuskar KA; Pulliam CF; Tomanek-Chalkley A; Rastogi P; Wen H; Dayal S; Griffin BR; Zepeda-Orozco D; Sindler AL; Anderson CM; Beardsley R; Kennedy EP; Spitz DR; Allen BG
    Redox Biol; 2024 Apr; 70():103022. PubMed ID: 38215546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avasopasem manganese (GC4419) protects against cisplatin-induced chronic kidney disease: An exploratory analysis of renal metrics from a randomized phase 2b clinical trial in head and neck cancer patients.
    Mapuskar KA; Vasquez Martinez G; Pulliam CF; Petronek MS; Steinbach EJ; Monga V; Furqan M; Jetton JG; Saunders DP; Pearce A; Davidson S; Pitre L; Dunlap NE; Fairbanks R; Lee CM; Mott SL; Bodeker KL; Cl H; Buatti JM; Anderson CM; Beardsley RA; Holmlund JT; Zepeda-Orozco D; Spitz DR; Allen BG
    Redox Biol; 2023 Apr; 60():102599. PubMed ID: 36640725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent increase in mitochondrial superoxide mediates cisplatin-induced chronic kidney disease.
    Mapuskar KA; Wen H; Holanda DG; Rastogi P; Steinbach E; Han R; Coleman MC; Attanasio M; Riley DP; Spitz DR; Allen BG; Zepeda-Orozco D
    Redox Biol; 2019 Jan; 20():98-106. PubMed ID: 30296702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NADPH oxidase 4 promotes cisplatin-induced acute kidney injury via ROS-mediated programmed cell death and inflammation.
    Meng XM; Ren GL; Gao L; Yang Q; Li HD; Wu WF; Huang C; Zhang L; Lv XW; Li J
    Lab Invest; 2018 Jan; 98(1):63-78. PubMed ID: 29106395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial modulation by Epigallocatechin 3-Gallate ameliorates cisplatin induced renal injury through decreasing oxidative/nitrative stress, inflammation and NF-kB in mice.
    Pan H; Chen J; Shen K; Wang X; Wang P; Fu G; Meng H; Wang Y; Jin B
    PLoS One; 2015; 10(4):e0124775. PubMed ID: 25875356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted inhibition of CX3CL1 limits podocytes ferroptosis to ameliorate cisplatin-induced acute kidney injury.
    Gong Q; Lai T; Liang L; Jiang Y; Liu F
    Mol Med; 2023 Oct; 29(1):140. PubMed ID: 37875838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-anemia drug FG4592 retards the AKI-to-CKD transition by improving vascular regeneration and antioxidative capability.
    Wu M; Chen W; Miao M; Jin Q; Zhang S; Bai M; Fan J; Zhang Y; Zhang A; Jia Z; Huang S
    Clin Sci (Lond); 2021 Jul; 135(14):1707-1726. PubMed ID: 34255035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Umbelliferone attenuates cisplatin-induced acute kidney injury by inhibiting oxidative stress and inflammation via NRF2.
    Yang Z; Ning R; Liu Q; Zang R; Liu S; Sun S
    Physiol Rep; 2023 Dec; 11(23):e15879. PubMed ID: 38030388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial Oxidative Metabolism: An Emerging Therapeutic Target to Improve CKD Outcomes.
    Mapuskar KA; Vasquez-Martinez G; Mayoral-Andrade G; Tomanek-Chalkley A; Zepeda-Orozco D; Allen BG
    Biomedicines; 2023 May; 11(6):. PubMed ID: 37371668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of renal mitochondrial respiratory complexes and manganese superoxide dismutase during sepsis: mitochondria-targeted antioxidant mitigates injury.
    Patil NK; Parajuli N; MacMillan-Crow LA; Mayeux PR
    Am J Physiol Renal Physiol; 2014 Apr; 306(7):F734-43. PubMed ID: 24500690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintaining homeostasis of mitochondria and endoplasmic reticulum with NSC228155 alleviates cisplatin-induced acute kidney injury.
    Li Y; Jiang Y; Zhou W; Wu Y; Zhang S; Ding G; Zhang Y; Zhang A; Huang S; Jia Z; You R
    Free Radic Biol Med; 2022 Mar; 181():270-287. PubMed ID: 35134531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astragalus propinquus Schischkin and Panax notoginseng (A&P) compound relieved cisplatin-induced acute kidney injury through inhibiting the mincle maintained macrophage inflammation.
    Hui D; Rui-Zhi T; Jian-Chun L; Xia Z; Dan W; Jun-Ming F; Li W
    J Ethnopharmacol; 2020 Apr; 252():112637. PubMed ID: 32004631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of monotropein on alleviating cisplatin-induced acute kidney injury by inhibiting oxidative damage, inflammation and apoptosis.
    Zhang Y; Chen Y; Li B; Ding P; Jin D; Hou S; Cai X; Sheng X
    Biomed Pharmacother; 2020 Sep; 129():110408. PubMed ID: 32574971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetylcysteine ameliorates cisplatin-induced renal senescence and renal interstitial fibrosis through sirtuin1 activation and p53 deacetylation.
    Li C; Xie N; Li Y; Liu C; Hou FF; Wang J
    Free Radic Biol Med; 2019 Jan; 130():512-527. PubMed ID: 30447351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hederagenin ameliorates cisplatin-induced acute kidney injury via inhibiting long non-coding RNA A330074k22Rik/Axin2/β-catenin signalling pathway.
    Xie KH; Liu XH; Jia J; Zhong X; Han RY; Tan RZ; Wang L
    Int Immunopharmacol; 2022 Nov; 112():109247. PubMed ID: 36155281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential role of nicotinamide adenine dinucleotide deficiency in acute and chronic kidney disease.
    Faivre A; Katsyuba E; Verissimo T; Lindenmeyer M; Rajaram RD; Naesens M; Heckenmeyer C; Mottis A; Feraille E; Cippà P; Cohen C; Longchamp A; Allagnat F; Rutkowski JM; Legouis D; Auwerx J; de Seigneux S
    Nephrol Dial Transplant; 2021 Jan; 36(1):60-68. PubMed ID: 33099633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective Effects of 6-Shogaol, an Active Compound of Ginger, in a Murine Model of Cisplatin-Induced Acute Kidney Injury.
    Gwon MG; Gu H; Leem J; Park KK
    Molecules; 2021 Sep; 26(19):. PubMed ID: 34641472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic acid protects against cisplatin-induced acute kidney injury and mitochondrial dysfunction through acting on ALDH1L2.
    Yang Y; Liu S; Gao H; Wang P; Zhang Y; Zhang A; Jia Z; Huang S
    Free Radic Biol Med; 2020 May; 152():821-837. PubMed ID: 32004633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors.
    Sato K; Watanabe S; Ohtsubo A; Shoji S; Ishikawa D; Tanaka T; Nozaki K; Kondo R; Okajima M; Miura S; Tanaka J; Sakagami T; Koya T; Kagamu H; Yoshizawa H; Narita I
    BMC Cancer; 2016 Mar; 16():222. PubMed ID: 26979596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydromyricetin attenuates cisplatin-induced acute kidney injury by reducing oxidative stress, inflammation and ferroptosis.
    Xu Z; Zhang M; Wang W; Zhou S; Yu M; Qiu X; Jiang S; Wang X; Tang C; Li S; Wang CH; Zhu R; Peng WX; Zhao L; Fu X; Patzak A; Persson PB; Zhao L; Mao J; Shu Q; Lai EY; Zhang G
    Toxicol Appl Pharmacol; 2023 Aug; 473():116595. PubMed ID: 37328118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.